Insider Transactions in Q4 2024 at Oncology Institute, Inc. (TOI)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 22
2024
|
Richard A Barasch Director |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+16.09%
|
-
|
|
Nov 22
2024
|
Mark L Pacala Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+27.11%
|
-
|
|
Nov 22
2024
|
Karen Marie Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
52,000
+23.72%
|
-
|
|
Nov 22
2024
|
Anne Mc George Director |
BUY
Grant, award, or other acquisition
|
Direct |
56,000
+23.4%
|
-
|
|
Nov 22
2024
|
Gabriel Ling Director |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+26.84%
|
-
|
|
Nov 22
2024
|
Mohit Kaushal Director |
BUY
Grant, award, or other acquisition
|
Direct |
56,000
+24.01%
|
-
|
|
Nov 22
2024
|
Brad Hively Director |
BUY
Grant, award, or other acquisition
|
Direct |
44,000
+5.76%
|
-
|
|
Nov 20
2024
|
Yale Podnos Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,002
-1.33%
|
$0
$0.14 P/Share
|
|
Nov 20
2024
|
Robert Ross Carter Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
235
-0.73%
|
$0
$0.14 P/Share
|
|
Nov 20
2024
|
Daniel Virnich Chief Executive Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,727
-0.68%
|
$0
$0.14 P/Share
|
|
Nov 12
2024
|
Yale Podnos Chief Medical Officer |
SELL
Other acquisition or disposition
|
Direct |
28,398
-14.6%
|
-
|
|
Nov 12
2024
|
Daniel Virnich Chief Executive Officer |
SELL
Other acquisition or disposition
|
Direct |
195,236
-11.24%
|
-
|
|
Nov 12
2024
|
Mark L Pacala Director |
SELL
Other acquisition or disposition
|
Direct |
50,620
-20.73%
|
-
|